Seeking Alpha

Brian Marckx, CFA

 
ABOUT
Brian Marckx, CFA is the Senior Medical Device / Diagnostics Analyst with Zacks Investment Research. I cover small and micro-cap medical device and diagnostic companies. Focus is development-stage companies with novel and emerging technologies as well as already established names still flying under the radar.

Prior to joining Zacks, Brian worked as a high-yield bond analyst on Wachovia Securities’ institutional trading desks where he specialized in the healthcare and industrials industries. Prior to that he was an analyst in corporate finance at First Union National Bank. Brian has covered the medical device, pharmaceutical and biotechnology industries since joining Zacks.

Brian has been quoted in ...More
SNAPSHOT
  • Description: Sell Side Research Analyst/Trader.
  • Interests: Bonds, Dividend stock ideas & income, Foreign stocks, Stocks - long, Stocks - short
COMPANY
Zacks Small Cap Research A division of Zacks Investment Research, Zacks Small-Cap Research covers small and micro-cap companies under-followed by Wall Street. Our in-depth fundamental research reports, commentary, valuation and financial models provide investors a unique opportunity to gain insight into companies generally overlooked ...More
BLOG
CombiMatrix (CBMX): Shift To Prenatal CMA Accelerating Growth. Initiating At Outperform CombiMatrix Corporation (CBMX), founded in 1995 and currently headquartered in Irvine, CA, is involved in the field of molecular diagnostics with a primary focus on prenatal and postnatal genetic testing, miscarriage/stillbirth management and the diagnosis of developmental disorders (and to a lesser extent ...More
Book
Currently, you have no book details. Click edit to add book details.
LATEST STOCKTALK more »
CombiMatrix Turns In Another Record Quarter, Stock Remains Undervalued $CBMX http://seekingalpha.com/a/1fmxt Aug 11, 2014